V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003060 | 210008759 | 1.67 | 57.2 | Neo-adjuvant (N) | 2015-11-06 | 2016-04-05 | CARBOPLATIN | null | N | CARBOPLATIN | 100109764 |
| 210003062 | 210008760 | null | null | null | null | 2020-02-23 | Palbociclib | 02 | null | CARBOPLATIN + PACLITAXEL | 100579457 |
| 210003063 | 210008761 | 1.52 | 87.5 | Adjuvant (A) | null | 2018-02-02 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100645397 |
| 210003064 | 210008762 | 1.62 | 0 | Palliative (P) | 2017-12-03 | 2018-04-28 | Capecitabine | null | N | CAPECITABINE | 101238725 |
| 210003067 | 210008764 | 1.72 | 72.8 | Neo-adjuvant (N) | null | 2019-02-17 | Carboplatin + Docetaxel | null | N | CARBOPLATIN + PACLITAXEL | 101080806 |
| 210003068 | 210008765 | 1.67 | 78.7 | null | 2018-12-03 | 2018-12-03 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100586804 |
| 210003069 | 210008766 | null | null | null | 2018-03-13 | 2018-03-13 | Bevacizumab | 02 | null | PALBOCICLIB | 101366534 |
| 210003071 | 210008768 | 1.58 | 87.6 | Neo-adjuvant (N) | 2021-05-13 | 2021-06-03 | Pertuzumab (Loading) | 02 | N | PERTUZUMAB | 100420339 |
| 210003072 | 210008769 | 1.61 | 54.7 | Adjuvant (A) | 2019-07-01 | 2019-07-09 | ROSCO Trial | 02 | N | CARBOPLATIN + PACLITAXEL | 100458010 |
| 210003073 | 210008770 | 1.55 | 69 | Adjuvant (A) | 2017-06-13 | 2020-06-19 | Epirubicin | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101675465 |
| 210003074 | 210008771 | 1.7 | 0 | Palliative (P) | 2019-05-30 | 2019-08-08 | Capecitabine | null | N | CAPECITABINE | 101289124 |
| 210003076 | 210008772 | null | null | null | 2014-12-13 | 2016-04-15 | Cyclophosphamide + Docetaxel | 02 | null | NAB-PACLITAXEL | 100182857 |
| 210003081 | 210008775 | null | null | null | 2022-03-02 | 2022-03-28 | CARBOPLATIN | null | null | CARBOPLATIN | 101022581 |
| 210003082 | 210008776 | 1.55 | 66 | Neo-adjuvant (N) | null | 2020-02-25 | Capecitabine | 02 | N | CAPECITABINE | 101529996 |
| 210003084 | 210008777 | null | 69.1 | null | 2018-03-22 | 2018-04-05 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101656772 |
| 210003086 | 210008778 | 1.6 | 57.2 | Neo-adjuvant (N) | null | 2016-07-23 | Eribulin | 02 | N | ERIBULIN | 100824734 |
| 210003087 | 210008779 | null | null | null | 2019-03-27 | 2019-04-28 | ROSCO Trial | null | null | FULVESTRANT + PALBOCICLIB | 100332921 |
| 210003088 | 210008780 | 1.48 | 90.4 | Adjuvant (A) | 2017-06-18 | 2017-06-25 | CARBOPLATIN | null | N | CARBOPLATIN | 100999924 |
| 210003089 | 210008781 | 1.61 | 54.6 | Palliative (P) | 2021-01-13 | 2021-04-30 | Capecitabine | 02 | N | CARBOPLATIN + PACLITAXEL | 101848035 |
| 210003090 | 210008782 | 1.59 | 55 | Palliative (P) | 2020-03-04 | 2020-05-17 | TOPOTECAN | null | N | CARBOPLATIN + DOCETAXEL | 100973773 |
| 210003091 | 210008783 | 1.5 | 73 | null | 2020-02-22 | 2020-02-27 | Capecitabine | N | null | CAPECITABINE | 100129135 |
| 210003092 | 210008784 | null | null | null | null | 2019-05-28 | null | 02 | null | EVEROLIMUS | 101342059 |
| 210003095 | 210008785 | 1.66 | 77.4 | Neo-adjuvant (N) | 2018-03-09 | 2018-03-16 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100787907 |
| 210003096 | 210008786 | null | 53 | null | null | 2020-06-10 | FEC 100 | 02 | null | ABEMACICLIB + FULVESTRANT | 101042671 |
| 210003099 | 210008788 | null | null | null | 2017-12-21 | 2018-03-10 | null | null | null | PALBOCICLIB | 101132912 |
| 210003100 | 210008789 | 1.74 | 82.8 | null | 2017-02-04 | 2017-06-19 | Capecitabine | 02 | null | CAPECITABINE | 100674209 |
| 210003101 | 210008790 | 1.6 | 72 | Palliative (P) | null | 2020-12-18 | Trial Unspecified | null | N | NAB-PACLITAXEL | 100956743 |
| 210003103 | 210008791 | 1.61 | 61.4 | Adjuvant (A) | 2016-10-06 | 2016-10-10 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101489039 |
| 210003105 | 210008792 | null | 78.4 | null | 2017-06-24 | 2017-07-24 | null | 02 | null | PALBOCICLIB | 100718817 |
| 210003107 | 210008793 | 1.58 | 101 | Palliative (P) | 2018-09-15 | 2018-09-19 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100351406 |
| 210003108 | 210008794 | 1.6 | 57.8 | Palliative (P) | 2016-07-20 | 2016-09-22 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101031930 |
| 210003111 | 210008795 | 1.66 | 81 | null | null | 2018-06-12 | TRASTUZUMAB DERUXTECAN | 02 | null | FULVESTRANT + PALBOCICLIB | 100304112 |
| 210003112 | 210008796 | 1.62 | 78.7 | Neo-adjuvant (N) | 2018-07-10 | 2018-09-22 | FEC | 02 | N | FEC | 100070955 |
| 210003114 | 210008798 | 1.54 | 53 | Palliative (P) | 2018-01-07 | 2020-08-18 | CARBOPLATIN + PACLITAXEL | 02 | N | ABEMACICLIB + FULVESTRANT | 101455719 |
| 210003116 | 210008799 | 1.7 | 77.2 | null | 2021-03-25 | 2021-04-06 | FEC | 02 | null | PALBOCICLIB | 100706292 |
| 210003118 | 210008800 | 1.54 | 95 | null | 2017-12-07 | 2018-03-17 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | FULVESTRANT + PALBOCICLIB | 100910715 |
| 210003119 | 210008801 | 1.6 | null | Adjuvant (A) | null | 2019-06-27 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101666789 |
| 210003120 | 210008802 | 1.57 | 86 | Palliative (P) | 2018-09-10 | 2018-10-09 | null | 02 | N | FULVESTRANT + PALBOCICLIB | 101240640 |
| 210003121 | 210008803 | 1.62 | 69.4 | Palliative (P) | 2021-04-03 | 2021-05-02 | Cyclophosphamide + Docetaxel | N | N | NAB-PACLITAXEL | 100552009 |
| 210003122 | 210008804 | 1.61 | 85.5 | null | 2019-02-03 | 2019-03-06 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101426855 |
| 210003127 | 210008806 | 0 | 0 | null | 2020-04-01 | 2020-04-23 | Neratinib | 02 | null | NERATINIB | 100351543 |
| 210003129 | 210008807 | 1.7 | 81.5 | Palliative (P) | 2019-11-25 | 2019-11-26 | Capecitabine | N | N | CAPECITABINE | 101151851 |
| 210003135 | 210008809 | 1.63 | 58.2 | Neo-adjuvant (N) | 2017-02-08 | 2017-02-09 | null | 02 | N | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101066007 |
| 210003136 | 210008810 | null | 130.05 | null | null | 2016-08-13 | null | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB | 101852150 |
| 210003137 | 210008811 | 1.54 | 87.2 | null | null | 2017-03-03 | Capecitabine | 02 | null | CAPECITABINE | 101688526 |
| 210003138 | 210008812 | 1.66 | 52.4 | null | 2017-06-04 | 2017-06-05 | null | 02 | null | LETROZOLE + RIBOCICLIB | 100463305 |
| 210003144 | 210008814 | 1.48 | 137.8 | null | null | 2020-01-18 | Capecitabine | 02 | null | NAB-PACLITAXEL | 100904106 |
| 210003146 | 210008816 | 1.48 | 76.9 | Neo-adjuvant (N) | 2020-12-13 | 2021-05-22 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100641036 |
| 210003147 | 210008817 | 1.62 | 64.4 | null | 2018-06-14 | 2018-06-23 | null | 02 | null | LETROZOLE + PALBOCICLIB | 101213383 |
| 210003148 | 210008818 | 1.51 | 72 | Palliative (P) | null | 2020-02-22 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 100550953 |